These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25491352)

  • 1. Linking system-wide impacts of RNA polymerase mutations to the fitness cost of rifampin resistance in Pseudomonas aeruginosa.
    Qi Q; Preston GM; MacLean RC
    mBio; 2014 Dec; 5(6):e01562. PubMed ID: 25491352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental Dependence of Competitive Fitness in Rifampin-Resistant
    Leehan JD; Nicholson WL
    Appl Environ Microbiol; 2022 Mar; 88(5):e0242221. PubMed ID: 35258334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental variation alters the fitness effects of rifampicin resistance mutations in Pseudomonas aeruginosa.
    Gifford DR; Moss E; MacLean RC
    Evolution; 2016 Mar; 70(3):725-30. PubMed ID: 26880677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epistasis between antibiotic resistance mutations and genetic background shape the fitness effect of resistance across species of Pseudomonas.
    Vogwill T; Kojadinovic M; MacLean RC
    Proc Biol Sci; 2016 May; 283(1830):. PubMed ID: 27170722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fitness cost of rifampicin resistance in Pseudomonas aeruginosa depends on demand for RNA polymerase.
    Hall AR; Iles JC; MacLean RC
    Genetics; 2011 Mar; 187(3):817-22. PubMed ID: 21220359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysing the fitness cost of antibiotic resistance to identify targets for combination antimicrobials.
    Rasouly A; Shamovsky Y; Epshtein V; Tam K; Vasilyev N; Hao Z; Quarta G; Pani B; Li L; Vallin C; Shamovsky I; Krishnamurthy S; Shtilerman A; Vantine S; Torres VJ; Nudler E
    Nat Microbiol; 2021 Nov; 6(11):1410-1423. PubMed ID: 34697460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genomic basis of adaptation to the fitness cost of rifampicin resistance in Pseudomonas aeruginosa.
    Qi Q; Toll-Riera M; Heilbron K; Preston GM; MacLean RC
    Proc Biol Sci; 2016 Jan; 283(1822):. PubMed ID: 26763710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampin resistance and its fitness cost in Riemerella anatipestifer.
    Sun J; Zhu D; Xu J; Jia R; Chen S; Liu M; Zhao X; Yang Q; Wu Y; Zhang S; Liu Y; Zhang L; Yu Y; You Y; Wang M; Cheng A
    BMC Microbiol; 2019 May; 19(1):107. PubMed ID: 31122209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fitness Cost of Rifampin Resistance in Neisseria meningitidis: In Vitro Study of Mechanisms Associated with rpoB H553Y Mutation.
    Colicchio R; Pagliuca C; Pastore G; Cicatiello AG; Pagliarulo C; Talà A; Scaglione E; Sammartino JC; Bucci C; Alifano P; Salvatore P
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7637-49. PubMed ID: 26416867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epistasis buffers the fitness effects of rifampicin- resistance mutations in Pseudomonas aeruginosa.
    Hall AR; MacLean RC
    Evolution; 2011 Aug; 65(8):2370-9. PubMed ID: 21790582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compensatory effects of
    Ma P; Luo T; Ge L; Chen Z; Wang X; Zhao R; Liao W; Bao L
    Emerg Microbes Infect; 2021 Dec; 10(1):743-752. PubMed ID: 33775224
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis.
    Mariam DH; Mengistu Y; Hoffner SE; Andersson DI
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1289-94. PubMed ID: 15047531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The distribution of fitness effects of beneficial mutations in Pseudomonas aeruginosa.
    MacLean RC; Buckling A
    PLoS Genet; 2009 Mar; 5(3):e1000406. PubMed ID: 19266075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifampin Resistance rpoB Alleles or Multicopy Thioredoxin/Thioredoxin Reductase Suppresses the Lethality of Disruption of the Global Stress Regulator spx in Staphylococcus aureus.
    Villanueva M; Jousselin A; Baek KT; Prados J; Andrey DO; Renzoni A; Ingmer H; Frees D; Kelley WL
    J Bacteriol; 2016 Oct; 198(19):2719-31. PubMed ID: 27432833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission.
    de Vos M; Müller B; Borrell S; Black PA; van Helden PD; Warren RM; Gagneux S; Victor TC
    Antimicrob Agents Chemother; 2013 Feb; 57(2):827-32. PubMed ID: 23208709
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Cutugno L; Mc Cafferty J; Pané-Farré J; O'Byrne C; Boyd A
    Microbiology (Reading); 2020 Dec; 166(12):1160-1170. PubMed ID: 33186092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of Rif(r) mutations in Pseudomonas aeruginosa and Pseudomonas putida.
    Jatsenko T; Tover A; Tegova R; Kivisaar M
    Mutat Res; 2010 Jan; 683(1-2):106-14. PubMed ID: 19887074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic characterization of compensatory evolution in strains carrying rpoB Ser531Leu, the rifampicin resistance mutation most frequently found in clinical isolates.
    Brandis G; Hughes D
    J Antimicrob Chemother; 2013 Nov; 68(11):2493-7. PubMed ID: 23759506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive phenotypic characterization of rifampicin resistance mutations in Salmonella provides insight into the evolution of resistance in Mycobacterium tuberculosis.
    Brandis G; Pietsch F; Alemayehu R; Hughes D
    J Antimicrob Chemother; 2015 Mar; 70(3):680-5. PubMed ID: 25362573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epistatic interactions between ancestral genotype and beneficial mutations shape evolvability in Pseudomonas aeruginosa.
    Gifford DR; Toll-Riera M; MacLean RC
    Evolution; 2016 Jul; 70(7):1659-66. PubMed ID: 27230588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.